| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.37B | +13.6% |
| Cost of Revenue | $1.72B | +18.3% |
| Gross Profit | $1.65B | +9.0% |
| R&D Expense | $376.5M | +27.7% |
| SG&A Expense | $893.8M | +22.5% |
| Operating Income | $253.1M | -42.1% |
| Interest Expense | $47.9M | +192.1% |
| Pre-tax Income | $206.9M | -62.0% |
| Income Tax | $91.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $183.4M | -62.4% |
| Accounts Receivable | $565.5M | +14.9% |
| Inventory | $1.07B | +10.3% |
| Current Assets | $2.05B | -5.1% |
| Total Assets | $5.81B | +36.6% |
| Current Liabilities | $1.28B | +6.6% |
| Long-term Debt | $2.09B | +63.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $251.3M | -28.2% |
| Capital Expenditures | $115.3M | +7.9% |
| Investing Cash Flow | -$1.76B | -439.0% |
| Financing Cash Flow | $1.23B | +735.9% |
| Free Cash Flow | $136.0M | -44.1% |
| -22.3% |
| Net Income | $113.1M | -73.5% |
| EPS (Basic) | $0.76 | -74.0% |
| EPS (Diluted) | $0.76 | -73.8% |
| Total Liabilities |
| $3.99B |
| +40.7% |
| Stockholders' Equity | $1.78B | +29.3% |